September 2020 | Innovate UK funding to develop preventive COVID-19 treatment
Researchers at the University of Liverpool are part of a new project to develop a novel, preventative nasal spray treatment for COVID-19. Read more...
February 2020 | Scientists to develop ‘radically different’ treatment for drug-resistant lung infections
A new European consortium research project aiming to develop novel treatments against drug-resistant bacterial respiratory infections is underway at the University of Liverpool. Funded by Horizon 2020, the €3.5 million ‘Light4Lungs’ project focuses on the treatment of antimicrobial resistance (AMR) in chronic lung infections, which are the leading cause of illness and death in patients with diseases such as cystic fibrosis and hospital-acquired lung infections. Read more...
November 2018 | Breakthrough in how deadly pneumococcus avoids immune defences
Scientists at the University of Liverpool have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design. Read more...
July 2018 | Infectious fun at Bluedot Festival
Staff and students from the University’s have taken part in this year’s Bluedot Festival at Jodrell Bank. Read more....
February 2018 | Research suggests vapers are vulnerable to pneumonia
The vapour from e-cigarettes could raise the risk of bacterial lung infections, new University of Liverpool research has found.
November 2017 | New funding to tackle antibiotic resistance
A new European research project aiming to help tackle the emergence and spread of drug-resistant superbugs is underway.
November 2017 | Saudi Ambassador to the UK Honours Outstanding Students
Prince Mohammed bin Nawaf bin Abdulaziz, Saudi Ambassador to the United Kingdom, has honoured 60 outstanding students in various disciplines at The Royal Embassy of Saudi Arabia.
March 2017 | Phage therapy shown to kill drug-resistant superbug
Scientists from the University of Liverpool’s have shown that phage therapy could offer a safe and effective alternative to antibiotics in the treatment of Cystic Fibrosis lung infections. Read More...
December 2016 | JPI-AMR
AMR in Streptococcus pneumoniae is spread globally by a limited number of clones. PCV vaccination has decreased AMR among vaccine-type strains. AMR now emerges by expansion of non-PCV types. The project focuses on genetic/functional properties of AMR clones with the goal to target their success and transmission in the carrier population..
December 2016 | 5 Year Programme Grant Awarded
Lead by Professor Aras Kadioglu, this project aims to improve our understanding of the process of natural colonisation and persistence of Streptococcus pneumoniae in the upper airways. We aim to uncover the interaction of bacteria with host cells in the airways in order to understand how silent infection occurs. Finally, we will determine what factors (bacterial, host or environmental) that lead from upper airway infection to the development of invasive disease.
November 2016 | Simple changes to antibiotic treatment of MRSA may help beat the bacteria
A study co-lead by Professor Aras Kadioglu have identified how MRSA may be more effectively treated by modern-day antibiotics, if old-fashioned penicillin is also used.
October 2016 | Action Medical Research Grant Awarded
Around 10,800 people in the UK – including over 4,000 children – have an inherited lung condition called cystic fibrosis (CF).1 Children with CF are susceptible to chest infections which can be difficult to treat, often persisting for the rest of a child’s life and reducing life expectancy. Dr Jo Fothergill, of the University of Liverpool, is investigating what makes these infections so difficult to treat, and how to diagnose them sooner, with the ultimate aim of protecting children from lifelong infections and improving their outlook.
September 2016 | Pre-clinical development of a new generation of pneumococcal vaccines.
Prof Aras Kadioglu, Dr Marie Yang and Dr Dean Everett were awarded £246,783 from Meningitis Now for the project “The preclinical development and evaluation of a mucosal protein-based adjuvanted vaccine against pneumococcal meningitis and sepsis”. Read More...
July 2016 | Hot Desert storms increase risk of bacterial meningitis in Africa
A study led by Professor Aras Kadioglu found that exposure to airborne dust and high temperatures are significant risk factors for bacterial meningitis.
May 2015 | Scientists discover bacterial cause behind fatal heart complications
A multidisciplinary research team, led by Professor Aras Kadioglu and Professor Cheng-Hock Toh, has discovered a key cause of life threatening heart complications that frequently follow severe infections with Streptococcus pneumoniae. Read more...
Nov 2014 | New treatment for life-threatening bacterial diseases identified
Research published in Nature Biotechnology shows that liposomes can be used to prevent bacterial toxins from killing human cells. Read more...
Sep 2014 | Researchers uncover hidden infection route of major bacterial pathogen
Research published in Nature Communications reports for the first time that Pseudomonas aeruginosa, which causes severe lung infections in people with cystic fibrosis, colonises the nasopharynx. Read more...
Jul 2014 | Mechanism that prevents lethal bacteria from causing invasive disease is revealed
An important development in understanding how Streptococcus pneumoniae, which causes pneumonia, meningitis and septicaemia, remains harmlessly in the nose and throat has been discovered. Read more...
Sep 2013 | Crafting Science at the Green Man Festival
PhD student Suzy Gore took part in this public engagement event with colleagues from the Institute, and spoke to festival-goers about her work. Read more...
Apr 2013 | Analysing meningitis genes to identify new treatments
New research, supported by Meningitis UK, is using advanced bioinformatics and infection biology tools to identify the bacterial meningitis genes and their products associated with disease so that they can be targeted for new treatments and vaccines. Read more...
May 2011 | New Professors join the University to tackle global infectious diseases
Professor Aras Kadioglu appointed to the as part of a wider £20 million initiative to attract world-class researchers to the University’s Faculty of Health and Life Sciences. Read more...
Back to: Institute of Infection, Veterinary and Ecological Sciences